tiprankstipranks
Trending News
More News >
InnoCan Pharma (TSE:INNO)
:INNO
Canadian Market

InnoCan Pharma (INNO) Ratios

Compare
22 Followers

InnoCan Pharma Ratios

TSE:INNO's free cash flow for Q3 2025 was $0.91. For the 2025 fiscal year, TSE:INNO's free cash flow was decreased by $ and operating cash flow was $-0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.99 4.09 2.68 9.41 3.51
Quick Ratio
4.17 2.61 1.99 7.86 3.37
Cash Ratio
3.45 2.24 1.53 6.77 3.10
Solvency Ratio
-0.71 -0.80 -1.83 -5.13 -2.81
Operating Cash Flow Ratio
0.19 -0.71 -1.54 -8.30 -1.86
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 10.31M$ 6.91M$ 4.25M$ 6.13M$ 8.96M
Leverage Ratios
Debt-to-Assets Ratio
0.14 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.55 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
0.35 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.35 0.00 0.00 0.00 0.00
Financial Leverage Ratio
4.01 1.79 1.69 1.09 1.39
Debt Service Coverage Ratio
-273.42 -31.43 0.00 -1.93K -769.54
Interest Coverage Ratio
-171.16 -178.14 0.00 -3.13K -575.38
Debt to Market Cap
0.09 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.47 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
4.06 -5.20 1.02 1.28 1.10
Profitability Margins
Gross Profit Margin
88.67%88.96%87.71%82.34%61.73%
EBIT Margin
-6.88%3.15%-27.85%-151.86%-5141.84%
EBITDA Margin
-6.74%3.26%-27.60%-150.49%-5119.90%
Operating Profit Margin
-5.78%-4.24%27.85%-244.86%-3816.33%
Pretax Profit Margin
-6.91%3.12%-29.54%-151.93%-5148.47%
Net Profit Margin
-10.92%-6.23%-34.41%-151.97%-5132.65%
Continuous Operations Profit Margin
-7.58%-0.89%-31.10%-151.97%-5148.47%
Net Income Per EBT
158.07%-199.56%116.51%100.03%99.69%
EBT Per EBIT
119.50%-73.70%-106.07%62.05%134.91%
Return on Assets (ROA)
-20.90%-19.81%-67.72%-55.75%-80.00%
Return on Equity (ROE)
-72.22%-35.49%-114.55%-60.82%-111.10%
Return on Capital Employed (ROCE)
-13.69%-17.76%86.49%-100.34%-83.01%
Return on Invested Capital (ROIC)
-13.69%5.06%86.06%-100.11%-82.75%
Return on Tangible Assets
-20.90%-19.81%-67.72%-55.75%-80.00%
Earnings Yield
-13.62%-4.60%-8.03%-10.10%-7.27%
Efficiency Ratios
Receivables Turnover
27.03 117.75 54.85 41.27 0.00
Payables Turnover
56.04 17.57 14.99 4.76 1.42
Inventory Turnover
1.37 0.98 0.96 0.40 0.15
Fixed Asset Turnover
318.27 260.50 100.42 26.11 3.63
Asset Turnover
1.91 3.18 1.97 0.37 0.02
Working Capital Turnover Ratio
2.99 5.27 2.62 0.34 0.07
Cash Conversion Cycle
273.36 354.85 362.09 845.44 2.22K
Days of Sales Outstanding
13.50 3.10 6.65 8.84 0.00
Days of Inventory Outstanding
266.37 372.52 379.78 913.31 2.48K
Days of Payables Outstanding
6.51 20.78 24.35 76.71 257.93
Operating Cycle
279.87 375.62 386.44 922.15 2.48K
Cash Flow Ratios
Operating Cash Flow Per Share
0.13 -0.38 -1.01 -1.62 -1.97
Free Cash Flow Per Share
0.12 -0.38 -1.02 -1.63 -1.98
CapEx Per Share
<0.01 <0.01 0.01 <0.01 0.01
Free Cash Flow to Operating Cash Flow
0.98 1.01 1.01 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
40.86 -105.27 -84.87 -233.35 -161.68
Capital Expenditure Coverage Ratio
40.86 -105.27 -84.87 -233.35 -161.68
Operating Cash Flow Coverage Ratio
0.27 -157.90 -118.30 -178.44 -6.63K
Operating Cash Flow to Sales Ratio
0.02 -0.05 -0.29 -2.37 -33.82
Free Cash Flow Yield
2.35%-4.00%-6.74%-15.82%-4.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-7.34 -21.73 -12.46 -9.90 -13.76
Price-to-Sales (P/S) Ratio
0.80 1.35 4.29 15.05 706.47
Price-to-Book (P/B) Ratio
6.16 7.71 14.27 6.02 15.29
Price-to-Free Cash Flow (P/FCF) Ratio
42.55 -25.00 -14.83 -6.32 -20.76
Price-to-Operating Cash Flow Ratio
41.51 -25.23 -15.00 -6.35 -20.89
Price-to-Earnings Growth (PEG) Ratio
0.05 0.34 -0.72 0.15 0.26
Price-to-Fair Value
6.16 7.71 14.27 6.02 15.29
Enterprise Value Multiple
-7.84 36.26 -14.51 -8.72 -12.70
Enterprise Value
15.64M 34.85M 54.71M 33.60M 127.42M
EV to EBITDA
-7.84 36.26 -14.51 -8.72 -12.70
EV to Sales
0.53 1.18 4.01 13.13 650.11
EV to Free Cash Flow
28.03 -21.86 -13.85 -5.51 -19.10
EV to Operating Cash Flow
27.35 -22.07 -14.01 -5.54 -19.22
Tangible Book Value Per Share
2.44 1.67 1.14 1.67 2.68
Shareholders’ Equity Per Share
0.86 1.23 1.06 1.71 2.69
Tax and Other Ratios
Effective Tax Rate
-0.36 1.29 -0.05 >-0.01 <0.01
Revenue Per Share
6.58 7.01 3.54 0.69 0.06
Net Income Per Share
-0.72 -0.44 -1.22 -1.04 -2.99
Tax Burden
1.58 -2.00 1.17 1.00 1.00
Interest Burden
1.00 0.99 1.06 1.00 1.00
Research & Development to Revenue
0.04 0.05 0.13 0.60 7.14
SG&A to Revenue
0.15 0.16 0.23 1.56 18.91
Stock-Based Compensation to Revenue
0.07 0.07 0.06 0.38 11.04
Income Quality
-0.25 6.03 0.83 1.56 0.66
Currency in USD